Aspirin does not improve survival for patients hospitalised with COVID-19, latest results from the RECOVERY trial show. The wide-ranging randomised trial studied the effect of aspirin in nearly 15,000 patients admitted to hospital between November 2020 and March 2021. Patients were randomised to aspirin 150 mg once daily or to usual care. There was no ...
Aspirin does not improve survival for patients admitted to hospital: RECOVERY
10 Jun 2021